Onkolytische Viren zur Behandlung von Krebserkrankungen

被引:0
作者
Katia Dittus
Adrian E. Eilert
Marie G. Szczeponik
Juliane K. Hastedt
Guy Ungerechts
Mathias F. Leber
机构
[1] Heidelberg/Nationales Centrum für Tumorerkrankungen (NCT),Klinische Kooperationseinheit „Virotherapie” Deutsches Krebsforschungszentrum (DKFZ)
[2] NCT Heidelberg,undefined
关键词
D O I
10.1007/s12268-023-2030-8
中图分类号
学科分类号
摘要
引用
收藏
页码:585 / 588
页数:3
相关论文
共 27 条
  • [1] Ameya G(2023)The molecular mechanisms of virus-induced human cancers Microb Pathog 183 106292-659
  • [2] Birri DJ(2007)History of oncolytic viruses: genesis to genetic engineering Mol Ther 15 651-605
  • [3] Kelly E(2018)Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines Cancer Cell 33 599-1959
  • [4] Russell SJ(2019)Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists Viruses 11 914-355
  • [5] Russell SJ(2014)CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy Mol Ther 22 1949-1106
  • [6] Barber GN(2021)MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer Mol Ther Oncolytics 21 340-380
  • [7] Backhaus PS(2023)Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference Viruses 15 308-40
  • [8] Veinalde R(2011)MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism Mol Ther 19 1097-undefined
  • [9] Hartmann L(2014)MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus Cancer Gene Ther 21 373-undefined
  • [10] Engeland CE(2018)Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites Mol Ther Oncolytics 9 30-undefined